{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:42:38Z","timestamp":1770691358339,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.npep.2021.102212","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:45:52Z","timestamp":1637433952000},"page":"102212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["NOP01, a NOP receptor agonist, produced potent and peripherally restricted antinociception in a formalin-induced mouse orofacial pain model"],"prefix":"10.1016","volume":"91","author":[{"given":"Jian","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiandong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangtai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2021.102212_bb0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1139\/cjpp-2017-0567","article-title":"Contribution of spinal 5-HT5A receptors to the antinociceptive effects of systemically administered cannabinoid agonist WIN 55,212-2 and morphine","volume":"96","author":"Aksu","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcpt.12404","article-title":"Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?","volume":"41","author":"Albert-Vartanian","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.npep.2021.102212_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2009.08.001","article-title":"Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats","volume":"619","author":"Ambriz-Tututi","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1527-3458.2005.tb00264.x","article-title":"UFP-101, a peptide antagonist selective for the nociceptin\/orphanin FQ receptor","volume":"11","author":"Calo","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.npep.2021.102212_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.regpep.2005.04.005","article-title":"Structure-activity studies on different modifications of nociceptin\/orphanin FQ: identification of highly potent agonists and antagonists of its receptor","volume":"130","author":"Chang","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2021.102212_bb0030","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.pain.2014.09.033","article-title":"TRPV4 is necessary for trigeminal irritant pain and functions as a cellular formalin receptor","volume":"155","author":"Chen","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.npep.2021.102212_bb0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0304-3940(89)90125-0","article-title":"Application of the formalin test to the study of orofacial pain in the rat","volume":"103","author":"Clavelou","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102212_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0304-3959(94)00273-H","article-title":"The orofacial formalin test in rats: effects of different formalin concentrations","volume":"62","author":"Clavelou","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.npep.2021.102212_bb0045","first-page":"299","article-title":"Fos, nociception and the dorsal horn","volume":"77","author":"Coggeshall","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.npep.2021.102212_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pbb.2011.08.007","article-title":"Antinociception induced by atorvastatin in different pain models","volume":"100","author":"Garcia","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102212_bb0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bdj.2017.879","article-title":"Orofacial pain - an update on diagnosis and management","volume":"223","author":"Ghurye","year":"2017","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.npep.2021.102212_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-019-1043-7","article-title":"Animal models of migraine and experimental techniques used to examine trigeminal sensory processing","volume":"20","author":"Harriott","year":"2019","journal-title":"J Headache Pain"},{"key":"10.1016\/j.npep.2021.102212_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3959(92)90131-T","article-title":"Stimulation of craniofacial muscle afferents induces prolonged facilitatory effects in trigeminal nociceptive brain-stem neurones","volume":"48","author":"Hu","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.npep.2021.102212_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/164_2019_211","article-title":"Effects of NOP-related ligands in nonhuman Primates","volume":"254","author":"Kiguchi","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.apha.2015.10.001","article-title":"Central N\/OFQ-NOP receptor system in pain modulation","volume":"75","author":"Kiguchi","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0085","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.2174\/1568026620666200508082615","article-title":"Nociceptin\/Orphanin FQ peptide receptor-related ligands as novel analgesics","volume":"20","author":"Kiguchi","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.npep.2021.102212_bb0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2021.102212_bb0095","series-title":"Orofacial Pain\u202f: Guidelines for Assessment, Diagnosis, and Management, Sixth","author":"Leeuw","year":"2018"},{"key":"10.1016\/j.npep.2021.102212_bb0100","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/bph.13489","article-title":"BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpain.2006.04.010","article-title":"The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception","volume":"7","author":"Luccarini","year":"2006","journal-title":"J. Pain"},{"key":"10.1016\/j.npep.2021.102212_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/FBP.0000000000000558","article-title":"Peripherally acting opioid analgesics and peripherally-induced analgesia","volume":"31","author":"Martinez","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.npep.2011.03.002","article-title":"The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction","volume":"45","author":"Mika","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102212_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1734-1140(13)70966-6","article-title":"Systemic synergism between codeine and morphine in three pain models in mice","volume":"65","author":"Miranda","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.npep.2021.102212_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044055","article-title":"Involvement of AMPA receptor GluR2 and GluR3 trafficking in trigeminal spinal subnucleus caudalis and C1\/C2 neurons in acute-facial inflammatory pain","volume":"7","author":"Miyamoto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2021.102212_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10787-009-0019-7","article-title":"Synergism between COX-3 inhibitors in two animal models of pain","volume":"18","author":"Munoz","year":"2010","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.npep.2021.102212_bb0135","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2174\/0929867325666180111095458","article-title":"Nociceptin \/Orphanin FQ peptide (NOP) receptor modulators: an update in structure-activity relationships","volume":"25","author":"Mustazza","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.npep.2021.102212_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.peptides.2006.11.004","article-title":"UFP-101 antagonizes the spinal antinociceptive effects of nociceptin\/orphanin FQ: behavioral and electrophysiological studies in mice","volume":"28","author":"Nazzaro","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102212_bb0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.120.000134","article-title":"Strategies for developing kappa opioid receptor agonists for the treatment of pain with fewer side effects","volume":"375","author":"Paton","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102212_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.regpep.2006.01.003","article-title":"Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N\/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N\/OFQ-NH2 of nociceptin\/orphanin FQ receptor","volume":"134","author":"Peng","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2021.102212_bb0155","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.npep.2021.102212_bb0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","article-title":"The orofacial formalin test","volume":"28","author":"Raboisson","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2021.102212_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2017.07.002","article-title":"Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test","volume":"94","author":"Rizzi","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102212_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1248\/bpb.b13-00690","article-title":"Sigma-1 receptor antagonist, BD1047 reduces nociceptive responses and phosphorylation of p38 MAPK in mice orofacial formalin model","volume":"37","author":"Roh","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.npep.2021.102212_bb0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.phrs.2010.02.011","article-title":"Analysis of the opioid-opioid combinations according to the nociceptive stimulus in mice","volume":"61","author":"Romero","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.npep.2021.102212_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1526-4610.2012.02226.x","article-title":"Spontaneous behavioral responses in the orofacial region: a model of trigeminal pain in mouse","volume":"53","author":"Romero-Reyes","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.npep.2021.102212_bb0185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.3131879","article-title":"Expression of c-fos protein in brain: metabolic mapping at the cellular level","volume":"240","author":"Sagar","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.npep.2021.102212_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2015.01.049","article-title":"Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin\/orphanin FQ receptor and micro-opioid receptor agonism","volume":"754","author":"Schiene","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0195","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1111\/bph.12744","article-title":"Functional plasticity of the N\/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists","volume":"171","author":"Schroder","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.08.002","article-title":"Behavioral differentiation between itch and pain in mouse","volume":"139","author":"Shimada","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.npep.2021.102212_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SPC.0000000000000495","article-title":"Opioid analgesia: recent developments","volume":"14","author":"Stein","year":"2020","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.npep.2021.102212_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.npep.2012.10.005","article-title":"Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models","volume":"47","author":"Teodoro","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102212_bb0215","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2021.102212_bb0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/164_2019_214","article-title":"NOP-related mechanisms in pain and analgesia","volume":"254","author":"Toll","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00702-016-1615-5","article-title":"A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study","volume":"124","author":"Veres","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.npep.2021.102212_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11916-017-0609-9","article-title":"Atypical facial pain: a comprehensive, evidence-based review","volume":"21","author":"Weiss","year":"2017","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.npep.2021.102212_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000871","article-title":"Potential of Nociceptin\/Orphanin FQ peptide analogs for drug development","volume":"18","author":"Wtorek","year":"2021","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.npep.2021.102212_bb0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu- and kappa-opioid receptors","volume":"177","author":"Xu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102212_bb0245","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1021\/acs.jmedchem.5b01499","article-title":"Nociceptin opioid receptor (NOP) as a therapeutic target: Progress in translation from preclinical research to clinical utility","volume":"59","author":"Zaveri","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2021.102212_bb0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.peptides.2018.10.010","article-title":"Analgesic activities of the mixed opioid and NPFF receptors agonist DN-9 in a mouse model of formalin-induced orofacial inflammatory pain","volume":"110","author":"Zhang","year":"2018","journal-title":"Peptides"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:37:47Z","timestamp":1758919067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417921000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":50,"alternative-id":["S0143417921000986"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2021.102212","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOP01, a NOP receptor agonist, produced potent and peripherally restricted antinociception in a formalin-induced mouse orofacial pain model","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2021.102212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102212"}}